Explore more publications!

Switzerland Weekly Press Releases

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
China-Singapore Tianjin Eco-City Becomes First Chinese City to Clinch Global Top Honor for Human Settlement Environment
ThinkCareBelieve: Week 43 of America's Climb into the Golden Age
Quiet Lab Mouthpiece Launches: A Scientific Breakthrough in QuietLab Anti-Snoring Devices and Sleep Health Innovation
Winter Sports Equiment Market 2025 : Expected to Reach $32.83 Billion by 2031
The inaugural edition of CARE in Dubai is set to accelerate green innovation and investment across the MENA region
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
World Ski Awards declares Cabane Tortin, Europe’s First High-Altitude Luxury Cabane, as World’s Best New Ski Chalet 2025
dacadoo Celebrates 15 Years of Innovation in Digital Health Engagement
Yachting: G-Spot Sets the Pace as Monaco Sportsboat Winter Series Opens
Festool Group Joins Emerald’s Industrial Innovation Fund to Accelerate Innovation and Sustainability
Molecular Cloning Market to Attain USD 8.89 Billion by 2034, Driven by Expanding Healthcare Applications and Innovation
Wound Care Centers Market to Attain USD 64.49 Billion by 2034, Driven by Rising Disease Burden and Healthcare Innovations
AMERICAN SWISS FOUNDATION ANNOUNCES THE YOUNG LEADER CLASS OF 2025
MyAmici and Kisco Partner to Deliver Best-in-Class Biotech Procurement Services in Switzerland
Cultured Meat Market to Hit $6,501.8 Million, Globally, by 2033 with a 58.5% CAGR
SGS Switzerland Supports CT UAV in Strengthening Aerospace Quality Standards Across Its 5 Plants and Headquarter
RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION
InSphero Expands 3D Cell Model Leadership with Acquisition of DOPPL SA and Sun Bioscience Gri3D® Technology
InSphero Expands 3D Cell Model Leadership with Acquisition of DOPPL SA and Sun Bioscience Gri3D Technology
Ariceum Therapeutics Doses First Patient in SANTANA-225 Phase 1/2 Clinical Trial of 225Ac-SSO110 in Patients with Extensive-Stage Small Cell Lung Cancer or Merkel Cell Carcinoma

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions